Manchester Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.35M Sell
21,891
-495
-2% -$115K 0.77% 19
2025
Q4
$4.63M Buy
22,386
+820
+4% +$162K 0.63% 25
2025
Q3
$4M Sell
21,566
-4,352
-17% -$746K 0.54% 27
2025
Q2
$3.96M Sell
25,918
-8,811
-25% -$1.35M 0.52% 31
2025
Q1
$5.76M Buy
34,729
+651
+2% +$102K 0.71% 23
2024
Q4
$4.93M Sell
34,078
-949
-3% -$147K 0.57% 33
2024
Q3
$5.68M Buy
35,027
+161
+0.5% +$25.7K 0.66% 25
2024
Q2
$5.1M Sell
34,866
-117
-0.3% -$17.4K 0.61% 29
2024
Q1
$5.53M Buy
34,983
+1,276
+4% +$203K 0.68% 26
2023
Q4
$5.28M Buy
33,707
+121
+0.4% +$18.6K 0.71% 24
2023
Q3
$5.23M Buy
33,586
+820
+3% +$135K 0.78% 21
2023
Q2
$5.42M Sell
32,766
-5,646
-15% -$911K 0.73% 22
2023
Q1
$5.95M Buy
38,412
+778
+2% +$126K 0.78% 19
2022
Q4
$6.65M Buy
37,634
+4,614
+14% +$797K 0.98% 18
2022
Q3
$5.39M Sell
33,020
-44
-0.1% -$7.45K 0.94% 18
2022
Q2
$5.87M Buy
33,064
+2,411
+8% +$430K 1.01% 18
2022
Q1
$5.43M Buy
30,653
+302
+1% +$51.4K 0.78% 21
2021
Q4
$5.19M Buy
30,351
+762
+3% +$125K 0.68% 23
2021
Q3
$4.78M Buy
29,589
+146
+0.5% +$24.9K 0.65% 22
2021
Q2
$4.85M Sell
29,443
-730
-2% -$121K 0.67% 21
2021
Q1
$4.96M Buy
30,173
+4,742
+19% +$767K 0.74% 18
2020
Q4
$4M Sell
25,431
-32
-0.1% -$4.72K 0.62% 22
2020
Q3
$3.79M Buy
25,463
+84
+0.3% +$12.4K 0.59% 22
2020
Q2
$3.57M Buy
25,379
+525
+2% +$76.5K 0.49% 26
2020
Q1
$3.26M Hold
24,854
0.52% 26
2019
Q4
$3.63M Buy
24,854
+574
+2% +$77.9K 0.4% 36
2019
Q3
$3.14M Sell
24,280
-1,222
-5% -$161K 0.37% 37
2019
Q2
$3.55M Sell
25,502
-2,055
-7% -$284K 0.46% 30
2019
Q1
$3.85M Buy
27,557
+494
+2% +$66.2K 0.49% 27
2018
Q4
$3.28M Buy
27,063
+396
+1% +$55.2K 0.5% 20
2018
Q3
$3.69M Sell
26,667
-396
-1% -$52.6K 0.53% 19
2018
Q2
$3.28M Buy
27,063
+4,579
+20% +$571K 0.5% 20
2018
Q1
$2.88M Buy
22,484
+139
+0.6% +$18.8K 0.46% 22
2017
Q4
$3.12M Sell
22,345
-149
-0.7% -$20.8K 0.47% 20
2017
Q3
$2.92M Sell
22,494
-1,652
-7% -$219K 0.45% 19
2017
Q2
$3.19M Sell
24,146
-1,473
-6% -$188K 0.51% 19
2017
Q1
$3.19M Buy
25,619
+1
+0% +$119 0.51% 20
2016
Q4
$2.95M Sell
25,618
-1,588
-6% -$183K 0.45% 22
2016
Q3
$3.21M Sell
27,206
-2,361
-8% -$286K 0.48% 19
2016
Q2
$3.59M Sell
29,567
-1,597
-5% -$181K 0.51% 19
2016
Q1
$3.37M Sell
31,164
-1,730
-5% -$179K 0.47% 23
2015
Q4
$3.38M Buy
32,894
+2,488
+8% +$250K 0.48% 24
2015
Q3
$2.84M Buy
30,406
+2
+0% +$193 0.48% 17
2015
Q2
$2.96M Buy
30,404
+21
+0.1% +$2.1K 0.47% 16
2015
Q1
$3.06M Sell
30,383
-5,329
-15% -$542K 0.48% 18
2014
Q4
$3.73M Sell
35,712
-633
-2% -$66.7K 0.46% 17
2014
Q3
$3.87M Sell
36,345
-83
-0.2% -$8.61K 0.52% 15
2014
Q2
$3.81M Buy
36,428
+561
+2% +$56.7K 0.51% 18
2014
Q1
$3.52M Buy
35,867
+772
+2% +$71.6K 0.57% 16
2013
Q4
$3.21M Sell
35,095
-999
-3% -$92.1K 0.5% 21
2013
Q3
$3.13M Sell
36,094
-743
-2% -$66.7K 0.54% 21
2013
Q2
$3.16M Buy
+36,837
New +$3.13M 0.59% 19

Other funds holding JNJ

Manchester Capital Management's JNJ Position: Q1 2026 in Review

Manchester Capital Management reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q1 2026, selling an estimated $115K and leaving 21,891 shares worth $5.35M. The position accounts for 0.77% of the portfolio, ranked #19.

Manchester Capital Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.65M in Q4 2022. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Manchester Capital Management held 21,891 shares of Johnson & Johnson worth $5.35M as of Q1 2026.
  • Manchester Capital Management sold 495 Johnson & Johnson shares in Q1 2026, an estimated $115K.
  • Johnson & Johnson made up 0.77% of Manchester Capital Management's portfolio in Q1 2026, its #19 holding.
  • Manchester Capital Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Manchester Capital Management's Johnson & Johnson position peaked at $6.65M in Q4 2022.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Manchester Capital Management's 13F filing for Q1 2026, filed 11 May 2026.